1203 related articles for article (PubMed ID: 29909233)
1. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
2. Intranasal ovalbumin immunotherapy with mycobacterial adjuvant promotes regulatory T cell accumulation in lung tissues.
Akkoç T; Genç D; Zibandeh N; Akkoç T
Microbiol Immunol; 2018 Aug; 62(8):531-540. PubMed ID: 29989252
[TBL] [Abstract][Full Text] [Related]
3. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma.
Böhm L; Maxeiner J; Meyer-Martin H; Reuter S; Finotto S; Klein M; Schild H; Schmitt E; Bopp T; Taube C
J Immunol; 2015 Feb; 194(3):887-97. PubMed ID: 25527785
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
5. Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells.
Su W; Zhong W; Zhang Y; Xia Z
BMC Immunol; 2012 Jul; 13():34. PubMed ID: 22769043
[TBL] [Abstract][Full Text] [Related]
6. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
Maazi H; Shirinbak S; Willart M; Hammad HM; Cabanski M; Boon L; Ganesh V; Baru AM; Hansen G; Lambrecht BN; Sparwasser T; Nawijn MC; van Oosterhout AJ
Clin Exp Allergy; 2012 Oct; 42(10):1519-28. PubMed ID: 22994349
[TBL] [Abstract][Full Text] [Related]
7. Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice.
Shakya AK; Lee CH; Gill HS
Mol Pharm; 2020 Aug; 17(8):3033-3042. PubMed ID: 32643940
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma.
Pellaton-Longaretti C; Boudousquié C; Barbier N; Barbey C; Argiroffo CB; Donati Y; Sauty A; Spertini F
Int Immunol; 2011 Jan; 23(1):17-27. PubMed ID: 21123830
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells.
Burchell JT; Wikstrom ME; Stumbles PA; Sly PD; Turner DJ
Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L307-19. PubMed ID: 19028981
[TBL] [Abstract][Full Text] [Related]
10. High dose vitamin D
Hesse L; van Ieperen N; Petersen AH; Elberink JNGO; van Oosterhout AJM; Nawijn MC
Sci Rep; 2020 Nov; 10(1):20876. PubMed ID: 33257771
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation.
Gogishvili T; Hahn C; Meinhard J; Hohaus A; Erb K; Sebald W; Bröcker EB; Grunewald SM
Int Arch Allergy Immunol; 2007; 142(2):165-74. PubMed ID: 17077644
[TBL] [Abstract][Full Text] [Related]
12. [Analyses of Foxp3
Matsuda M; Terada T; Kitatani K; Kawata R; Nabe T
Nihon Yakurigaku Zasshi; 2019; 154(1):17-22. PubMed ID: 31308345
[TBL] [Abstract][Full Text] [Related]
13. Regulation of allergic airway inflammation by adoptive transfer of CD4
Matsuda M; Doi K; Tsutsumi T; Fujii S; Kishima M; Nishimura K; Kuroda I; Tanahashi Y; Yuasa R; Kinjo T; Kuramoto N; Mizutani N; Nabe T
Eur J Pharmacol; 2017 Oct; 812():38-47. PubMed ID: 28668505
[TBL] [Abstract][Full Text] [Related]
14. IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.
Chen CC; Kobayashi T; Iijima K; Hsu FC; Kita H
J Allergy Clin Immunol; 2017 Nov; 140(5):1351-1363.e7. PubMed ID: 28196763
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells.
Lin CL; Hsiao G; Wang CC; Lee YL
Pharmacol Res; 2016 Aug; 110():111-121. PubMed ID: 27185659
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Allergen-Responsive Regulatory T Cells in Experimental Asthma Induced in Different Mouse Strains.
Azevedo CT; Cotias AC; Arantes ACS; Ferreira TPT; Martins MA; Olsen PC
Mediators Inflamm; 2021; 2021():7584483. PubMed ID: 34924814
[TBL] [Abstract][Full Text] [Related]
17. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab ameliorates OVA-induced airway inflammation in mice: Role of CD4(+) CD25(+) FOXP3(+) regulatory T-cells.
Elsakkar MG; Sharaki OA; Abdallah DM; Mostafa DK; Shekondali FT
Eur J Pharmacol; 2016 Sep; 786():100-108. PubMed ID: 27262379
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of type 1 regulatory T cells suppressed the development of airway hyperresponsiveness in ovalbumin-induced airway inflammation model mice.
Matsuda M; Doi K; Tsutsumi T; Inaba M; Hamaguchi J; Terada T; Kawata R; Kitatani K; Nabe T
J Pharmacol Sci; 2019 Dec; 141(4):139-145. PubMed ID: 31744690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
